Elias Aboujaoude, MD, MA

Publication Details

• Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation.

  Koran LM, Gamel NN, Choung HW, Smith EH, Aboujaoude EN. J Clin Psychiatry. 2005; 66 (4): 515-20

  Many patients with obsessive-compulsive disorder (OCD) experience little response to standard treatment with serotonin reuptake inhibitors. Mirtazapine enhances serotonergic function by a mechanism distinct from reuptake inhibition. Because a pilot study suggested effectiveness of mirtazapine in OCD, we conducted a controlled trial.

  PubMedID: 15816795